CTIX market cap is 152 million. Unbelievable that a company with all these clinical trials going on has such a low valuation. By comparison, AVXL (which I also own) has a market cap of 160 million. It has one small clinical trial going, in the very risky Alzheimer's area. Very few Alz clinical trials result in a usable drug (although AVXL's is looking very good so far and will be a blockbuster if it gives any kind of decent results).

So, we have a company with multiple successful clinical trials in several completely different areas, with a market cap of 152 million. We have another company valued at 160 million, with one very small clinical trial in a much riskier area -- and if that clinical trial doesn't pan out, it is likely the company will go bankrupt.

How does CTIX's valuation make any sense? Answer: it doesn't, and it wouldn't be trading here if not for a massive short attack and stock manipulation.